Cargando…
Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A Case-Control Study
OBJECTIVE: To test the usefulness of serum concentrations of tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and soluble scavenger receptor CD163 (sCD163) as markers of subtle inflammation in patients with type 1 diabetes mellitus (T1DM) without clinical cardiovascular (CV) disease and...
Autores principales: | Llauradó, Gemma, González-Clemente, José-Miguel, Maymó-Masip, Elsa, Subías, David, Vendrell, Joan, Chacón, Matilde R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3427173/ https://www.ncbi.nlm.nih.gov/pubmed/22937125 http://dx.doi.org/10.1371/journal.pone.0043919 |
Ejemplares similares
-
Serum sCD163 Levels Are Associated with Type 2 Diabetes Mellitus and Are Influenced by Coffee and Wine Consumption: Results of the Di@bet.es Study
por: Rojo-Martínez, Gemma, et al.
Publicado: (2014) -
TWEAK: A New Player in Obesity and Diabetes
por: Vendrell, Joan, et al.
Publicado: (2013) -
New Insights in Cytokines in Childhood Obesity: Changes in TWEAK and CD163 After a 2-Year Intervention Program in Prepubertal Children With Obesity
por: Escartín, Rocío, et al.
Publicado: (2022) -
HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels
por: López-Dupla, Miguel, et al.
Publicado: (2015) -
The TWEAK/Fn14/CD163 axis—implications for metabolic disease
por: Ratajczak, Wiktoria, et al.
Publicado: (2021)